Acute Erythroblastic Leukemia is a rare form of acute myeloid leukemia in which the myeloproliferation is the erythroblastic precursors. In the blood and bone marrow, a large amount of immature blood cells are produced and,in advance forms, can make up over 50% of the cells in the blood and marrow causing oxygen to be unable to be delivered throughout the body. Lack of oxygen, otherwise known as anemia, causes patients to feel weak and fatigued. Red blood cells are not the only cells affected in Acute Erythroblastic Leukemia; patients also have very low white blood cells and platelet numbers. This form of leukemia is a very aggressive form and is not easily treated with common types of therapy.
Acute Erythroblastic Leukemia Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Acute Erythroblastic Leukemia below!
For more information on how to use Laverne, please read the How to Guide.
We have 2943 products for the study of Acute Erythroblastic Leukemia that can be applied to Flow Cytometry, Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.
Acute Erythroblastic Leukemia is also known as acute erythroblastic leukemia.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.